GlassScriptPhysician profile
Jill Bowman
NPI 1386196251
$854.84
in general payments reported to CMS, 2019-2025
12 companies · $63.73 in 2025
The $63.73 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $727 · 2022: $64.45 · 2025: $63.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $63.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $63.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $241.07 | 2021-2022 | |
| Abbvie INC. | $177.55 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $120.04 | 2021 | |
| Microvention, INC. | $63.73 | 2025 | Balloon Catheter, Sofia 6f-131cm Str, Stent |
| Astrazeneca Pharmaceuticals LP | $57.72 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.22 | 2021 | |
| Janssen Pharmaceuticals, INC | $51.08 | 2021 | |
| Clarus Therapeutics INC. | $26.86 | 2021 | |
| Merck Sharp & Dohme LLC | $18.77 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.00 | 2021 | |
| Glaxosmithkline, LLC. | $15.81 | 2021 | |
| Lilly USA, LLC | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.